About Inferal
Inferal is a private company based in San Francisco, California, incorporated in 2023 in Delaware. It has reported $1,655,000 raised in two offerings on Form D since September 2023.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 17, 2026 | May 8, 2026amended May 11, 2026 | $250,000of $1.0M target | 1 | $250K | Simple Agreement for Future Equity ("SAFE")Rule 506(b) | Form D/A ↗1 earlier filing |
| Aug 16, 2023 | Sep 6, 2023amended Nov 3, 2023 | $1,405,000of $1.7M target | 12 | $117K | Simple Agreement for Future Equity ("SAFE")Rule 506(b) | Form D/A ↗1 earlier filing |
| Total, two offerings | $1,655,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Inferal's Form D filed May 11, 2026.
IR
Iurii Rashkovskyi
Chief Financial Officer and director
Earlier filings also listed Vignesh Ravichandran (executive officer and director, last listed Nov 2023).